| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joshua S. Lev | CFO and Interim President | 2026-05-28 | 6,667 | $9.00 | $60.00kSell |
| Joshua S. Lev | CFO and Interim President | 2026-05-22 | 3,000 | $6.50 | $19.50kSell |
| Thomas J. Errico | Director | 2026-05-21 | 9,992 | $5.99 | $59.85kBuy |
| Thomas J. Errico | Director | 2026-05-20 | 8 | $5.98 | $47.84Buy |
| Daniel S. Goldberger | Insider | 2026-04-10 | 16,072 | $6.02 | $96.75kSell |
| Thomas J. Errico | Director | 2026-03-19 | 19,252 | $6.43 | $123.79kBuy |
| Thomas J. Errico | Director | 2026-03-19 | 22,803 | $4.35 | $99.19kBuy |
| Daniel S. Goldberger | Chief Executive Officer | 2026-01-26 | 20,375 | $7.47 | $152.20kBuy |
| Joshua S. Lev | Chief Financial Officer | 2025-12-04 | 2,500 | $5.05 | $12.63kSell |
| Daniel S. Goldberger | Chief Executive Officer | 2025-12-02 | 1,000 | $4.84 | $4.84kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph P. Errico | 46.55% | 3,861,942 | $38.08M | Insider |
| Merck Global Health Innovation Fund LLC | 40.33% | 3,346,032 | $32.99M | Insider |
| James L. L. Tullis | 24.28% | 2,014,110 | $19.86M | Insider |
| Thomas J. Errico | 12.84% | 1,065,161 | $10.50M | Insider |
| Core Ventures II LLC | 7.79% | 646,342 | $6.37M | Insider |
| Peter S. Staats | 5.74% | 476,419 | $4.70M | Insider |
| Charles Steve Theofilos | 5.58% | 462,758 | $4.56M | Insider |
| Francis R. Amato | 4.44% | 368,355 | $3.63M | Insider |
| Daniel S. Goldberger | 3.51% | 291,471 | $2.87M | Insider |
| Vanguard Capital Management LLC | 2.44% | 202,644 | $2.00M | Institution |